Chronic Urticaria in Pregnancy or Lactation — When the Initial Antihistamine Regimen Falls Short
Clinical scenario
This protocol applies to women with chronic urticaria who are pregnant or breastfeeding and have not achieved complete symptom control on first-line therapy. Managing urticaria in this population requires careful risk–benefit assessment, as several agents are contraindicated or unsuitable during pregnancy and lactation.
First-line treatment — escalation trigger
The previous step used a modern 2nd generation H1-antihistamine — preferring loratadine and cetirizine, with 1st generation agents avoided — as the foundational approach. When that step does not achieve complete symptom control (a continuous urticaria activity score of 0 and a urticaria control test score of 16), this next-line protocol applies.
Next-step approach (partial overview)
The next clinical step involves a carefully considered adjustment in the dosing of the same class of modern 2nd generation H1-antihistamine, with specific caution applied given the pregnancy or lactation context. The complete structured regimen — including which agents are appropriate, the relevant safety constraints, and the full clinical algorithm — is available in the full protocol.
Treatment goal
Complete symptom control: a continuous UAS of 0 and a UCT score of 16, alongside normalisation of quality of life.
References
DOI: 10.1111/all.70210
- We suggest using the same treatment algorithm with caution both in pregnant and lactating women after risk-benefit assessment.
- Drugs contraindicated or not suitable in pregnancy should not be used.
- The increased dosage of modern 2nd generation H1-antihistamines can only be carefully suggested in pregnancy since safety studies have not been done, and with loratadine it must be remembered that this drug is metabolized in the liver which is not the case for its metabolite desloratadine.
- The goal of treatment is to treat the disease until it is gone, as efficiently and as safely as possible, aiming at a continuous complete control (consistently UAS = 0/UCT = 16) and a normalization of quality of life.
View source ↗